Mogrol

CAS No. 88930-15-8

Mogrol ( —— )

Catalog No. M24913 CAS No. 88930-15-8

Mogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 140 In Stock
10MG 237 In Stock
25MG 475 In Stock
50MG 671 In Stock
100MG 896 In Stock
500MG 1791 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mogrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Mogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.
  • Description
    Mogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK1; ERK2; STAT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88930-15-8
  • Formula Weight
    476.7
  • Molecular Formula
    C30H52O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:110 mg/mL?(230.74 mM;?Need ultrasonic)
  • SMILES
    CC1(C)[C@@H](O)CC[C@@]2([H])[C@]3(C)[C@H](O)C[C@]4(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)(O)C)CC[C@](C)4[C@]3([H])CC=C12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu C, et al. Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition. Am J Cancer Res. 2015 Mar 15;5(4):1308-18.
molnova catalog
related products
  • Poncirin

    Poncirin shows a significant in vitro inhibitory effect on the growth of the human gastric cancer cells, SGC-791, in a dose-dependent manner.

  • Tussilagone

    Tussilagone inhibits dendritic cell function through the induction of heme oxygenase-1.

  • BAY-885

    BAY-885 (BAY885) is a highly potent, selective ERK5 (MAPK7) inhibitor with IC50 of 40 nM.